Endogenous volatile organic compounds in acute myeloid leukemia: origins and potential clinical applications

Journal of Breath Research
Dibyendu DuttaSeah H Lim

Abstract

Not unlike many cancer types, acute myeloid leukemia (AML) exhibits many metabolic changes and reprogramming, causing changes in lipid metabolism. Some of the distinct molecular abnormalities associated with AML also modify the metabolic changes. Both processes result in changes in the production of endogenous volatile organic compounds (VOCs). The increasing availability of highly sensitive methods for detecting trace chemicals provides the opportunity to investigate the role of patient-specific VOC finger-prints as biomarkers for detecting early relapse or minimal residual disease in AML. Since VOC production is reliant on metabolic activities, when combined with currently available methods, VOC analysis may identify within a group of patients with flow cytometric or molecular evidence of residual disease those most at risk for disease relapse.

References

Feb 15, 1997·Analytical Chemistry·C Grote, J Pawliszyn
Dec 16, 1998·International Journal of Molecular Medicine·I MüllerG Bruchelt
May 10, 2000·Free Radical Biology & Medicine·E Aghdassi, J P Allard
Feb 13, 2001·Journal of Applied Physiology·J K SchubertJ Guttmann
May 29, 2002·Oncogene·Barbara HoffmanDan A Liebermann
Jun 11, 2003·Chest·Michael PhillipsWilliam N Rom
Sep 13, 2003·Leukemia·M Levis, D Small
Nov 13, 2003·Molecular and Cellular Biology·Salvador MacipStuart A Aaronson
Jul 21, 2004·Cancer Cell·Reuben J ShawLewis C Cantley
Jul 21, 2004·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Chunhui DengNing Li
Aug 18, 2004·Clinica Chimica Acta; International Journal of Clinical Chemistry·Wolfram MiekischGabriele F E Noeldge-Schomburg
Aug 18, 2004·The International Journal of Biochemistry & Cell Biology·Juan Du, Janusz M Gebicki
Jan 24, 2007·Physiological Reviews·Karen Bedard, Karl-Heinz Krause
Jul 25, 2007·Internal Medicine Journal·I A ScottP J Poole
Jul 27, 2007·Annals of Hematology·Johnny AmerEitan Fibach
Nov 23, 2007·Proceedings of the National Academy of Sciences of the United States of America·Ralph J DeBerardinisCraig B Thompson
Feb 12, 2008·Journal of Cellular Physiology·Sara Rodríguez-EnríquezRafael Moreno-Sánchez
Nov 27, 2008·Proceedings of the National Academy of Sciences of the United States of America·David R WiseCraig B Thompson
Dec 9, 2008·The Biochemical Journal·Michael P Murphy
May 1, 2009·Journal of Translational Medicine·Hye-Won ShinDan M Cooper
Mar 7, 1927·The Journal of General Physiology·O WarburgE Negelein
Nov 13, 2009·Respiratory Medicine·J J B N Van BerkelF J Van Schooten
Feb 13, 2010·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Diana PoliAntonio Mutti
Jun 15, 2010·Clinica Chimica Acta; International Journal of Clinical Chemistry·Sabine KischkelJochen K Schubert
Oct 12, 2010·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Iwao NakabayashiMasaharu Yoshida
Jun 1, 2009·Journal of Breath Research·Jens Herbig, Anton Amann
Sep 1, 2009·Journal of Breath Research·Wolfgang VautzJörg Ingo Baumbach

❮ Previous
Next ❯

Citations

Feb 14, 2020·International Journal of Environmental Research and Public Health·Zehra Nur TöreyinLode Godderis

❮ Previous
Next ❯

Related Concepts

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.